FDA concedes delays in response to baby formula shortage

The Food and Drug Administration acknowledged Tuesday that its response to the U.S. infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.

A 10-page report from the agency offers its first formal account of the factors that led to the ongoing shortage, which has forced the U.S. to airlift millions of pounds of powdered formula from overseas.

The review zeroed in on several key problems at the regulatory agency, including outdated data-sharing systems, inadequate staff and training for food regulators, and poor visibility into formula supply chains and manufacturing procedures.


Disclaimer: This article may require a subscription.

Leave a Comment